KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $12.7 billion.

  • Amgen's Other Non-Current Assets rose 2749.24% to $12.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $12.7 billion, marking a year-over-year increase of 2749.24%. This contributed to the annual value of $12.7 billion for FY2025, which is 2749.24% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Other Non-Current Assets is $12.7 billion, which was up 2749.24% from $13.2 billion recorded in Q3 2025.
  • Amgen's 5-year Other Non-Current Assets high stood at $13.2 billion for Q3 2025, and its period low was $5.8 billion during Q1 2021.
  • Over the past 5 years, Amgen's median Other Non-Current Assets value was $7.7 billion (recorded in 2023), while the average stood at $8.4 billion.
  • As far as peak fluctuations go, Amgen's Other Non-Current Assets plummeted by 958.0% in 2022, and later skyrocketed by 6292.59% in 2023.
  • Quarter analysis of 5 years shows Amgen's Other Non-Current Assets stood at $6.5 billion in 2021, then decreased by 9.58% to $5.9 billion in 2022, then surged by 62.93% to $9.6 billion in 2023, then rose by 3.32% to $9.9 billion in 2024, then increased by 27.49% to $12.7 billion in 2025.
  • Its last three reported values are $12.7 billion in Q4 2025, $13.2 billion for Q3 2025, and $11.0 billion during Q2 2025.